Medtronic plc
20 Hatch Street Lower, Dublin, D
Related Posts:
Medicare approves coverage for Medtronic’s Symplicity Spyral blood pressure procedure
October 28, 2025
Medtronic plc announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a National Coverage Determination (NCD) for renal denervation, specifically applying to the Symplicity Spyral renal denervation (RDN) system.
Read more →
Medtronic reports sustained blood pressure reduction at three years with Symplicity Spyral device
October 26, 2025
Medtronic plc has announced new three-year results from the SPYRAL HTN-ON MED clinical trial, showing that patients treated with its Symplicity Spyral renal denervation (RDN) procedure experienced greater and sustained reductions in blood pressure...
Read more →
Medtronic’s BrainSense adaptive deep brain stimulation named among TIME Best Inventions for 2025
October 9, 2025
Medtronic plc announced that its BrainSense Adaptive Deep Brain Stimulation (aDBS) system has been named one of TIME’s Best Inventions for 2025.
Read more →
Medtronic launches US clinical trial evaluating Hugo robotic system for gynecology
October 8, 2025
Medtronic plc has begun a new clinical study in the United States to evaluate its Hugo robotic-assisted surgery (RAS) system for use in gynecological procedures.
Read more →
Medtronic closes €1.5 billion public offering of senior notes
September 29, 2025
Medtronic plc announced that its indirect subsidiary, Medtronic, Inc., has completed a public offering of €1.5 billion in senior notes.
Read more →
Medtronic prices €1.5 billion in senior notes for debt repayment
September 15, 2025
Medtronic plc announced that its indirect subsidiary, Medtronic, Inc., has priced a €1.5 billion offering of senior notes.
Read more →
Medtronic launches global trial studying new pacemaker use for heart failure patients
September 15, 2025
Medtronic plc has started a global pivotal study to evaluate a new approach to cardiac pacing for patients with heart failure with preserved ejection fraction (HFpEF).
Read more →
Medtronic reports positive results from first US IDE trial on Hugo robot-assisted hernia surgery
September 4, 2025
Medtronic plc has announced the results of its Enable Hernia Repair clinical study, which evaluated the performance of the Hugo robotic-assisted surgery (RAS) system in both inguinal and ventral hernia repair procedures.
Read more →
FDA clears new integrations and expanded indications for Medtronic MiniMed™ 780G
September 2, 2025
Medtronic plc announced that the U.S. Food and Drug Administration (FDA) has cleared its SmartGuard algorithm as an interoperable automated glycemic controller, which will allow integration with Abbott's Instinct sensor for people with type 1...
Read more →
Trending
The Weekly Newsletter
Sign-up for the Weekly Newsletter from EU Business Daily.